Results
Evonile Pharma Q2 Revenue ₹56.1 Cr, EBITDA -₹31.8 Cr
Evonile Pharma announces unaudited Q2 FY27 results with ₹56.1 crore revenue and negative ₹31.8 crore EBITDA due to transition costs.
Company completed transition to independent business model after Ch
